Capital World Investors Exact Sciences Corp Transaction History
Capital World Investors
- $586 Billion
- Q1 2024
A detailed history of Capital World Investors transactions in Exact Sciences Corp stock. As of the latest transaction made, Capital World Investors holds 13,025,313 shares of EXAS stock, worth $539 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
13,025,313
Previous 7,468,145
74.41%
Holding current value
$539 Million
Previous $552 Million
62.81%
% of portfolio
0.15%
Previous 0.1%
Shares
17 transactions
Others Institutions Holding EXAS
# of Institutions
699Shares Held
160MCall Options Held
5.84MPut Options Held
2.58M-
Vanguard Group Inc Valley Forge, PA17.7MShares$734 Million0.02% of portfolio
-
Jpmorgan Chase & CO New York, NY12.4MShares$512 Million0.08% of portfolio
-
Black Rock Inc. New York, NY11.4MShares$471 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA10.7MShares$442 Million0.13% of portfolio
-
State Street Corp Boston, MA5.09MShares$211 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $7.32B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...